Predictors of long-term response and survival in patients with extensive stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus chemotherapy in a real-world setting (IFCT-1905 CLINATEZO)
Auteurs / Authors: L. Falchero
, K. Amrane
, B. Godbert
, B. Leterre
, J. Madelaine
,P. Fournel
, C. Mascaux
, J. Raimbourg
, S. Schneider
, A. Swalduz,
R. Veillon, A. Langlais, P. Missy, F. Morin, V. Westeel,
N. Girard
Journal / Conference: ELCC
Année / Year: 2025
PMID: Poster session
Lien vers la publication: https://www.jto.org/article/S1556-0864(25)00506-4/fulltext#:~:text=In%20this%20analysis%2C%20predictors%20of%20long-term%20response%20%28defined,assessed.%20518%20patients%20were%20enrolled%20from%2065%20centers.
